For increasedclinicalapplicationsof nucleic acid probes to gene diagnosis, current procedures must be modified to become more amenable to the rapid processing of many samples with as few manipulations as possible. Here we summarize progress in the development of a strategy for performing molecular hybridization directly in lysate of biological samples dissolved in solutions containing the chaotropic agent, guanidine thiocyanate. Hybrids are purified by a process referred to as "reversible target capture," in which specific nucleic acid sequences are rapidly purified from crude lysate. We illustrate the use of this strategy to assay HIV-1 RNA and to rapidly purify HIV-1 RNA before enzymatic amplification by the polymerase chain reaction method.
Guanidine thiocyanate supports molecular hybridization (2), and is a potent inhibitor of cellular nucleases (6). Nucleic acid probes were then added, and hybridization was accomplished at 37 #{176}C directly in the lysate. The advantage of this strategy was that nucleic acids did not need to be extracted and purified before hybridization.
Also, molecular hybridization was driven in solution with excess probe-a more rapid and efficient reaction than the more-conventional blot hybridization strategy, in which hybridization occurs between probe in solution and target nucleic acids immobilized on membranes. In addition, this approach obviated uncertainties arising from loss of nucleic acids during purification and binding to membranes.
We also adopted a strategy referred to as " target capture" (3), to selectively purify hybrids from the crude cell lysate after hybridization. In this method, two types of probes were hybridized, a "labelprobe," which provided signal, and a dA-tailed synthetic oligonucleotide "captureprobe," which allowed for selective purification of the target nucleic acid. After hybridization, ternary hybrids-consisting of the target nucleic acid, the labelprobe, and the captureprobe-were captured onto paramagnetic beads coated with oligo-dT (dT-beads), which bound to the poly(dA) portion of the captureprobe (3). In this sandwich hybridization strategy, labelprobe cannot bind to beads unless it is bound to target, and the target is bound by a captureprobe. The advantage of this capture strategy is the reversible nature of the captureprobe:bead interaction. Ternary hybrids can be eluted from dT-beads simply by raising the concentration of chaotrope, then recaptured onto fresh dT-beads by lowering the chaotrope concentration. Repeated cycles of capture effectively eliminated background associated with the nonspecific interaction of labelprobe with material in the lysate, and dT-beads, thereby increasing the range of sensitivity (3) (4) (5) . In this strategy, the specificity of hybridization can be adjusted via both the labelprobe and the captureprobe, thereby increasing the confidence that signals result from true probe:target interactions.
Reversible target capture can also potentially be used to purify target nucleic acids, which can then be used for further manipulation. Nucleic acids can be purified by performing hybridization with captureprobe alone, capturing the hybrid onto dT-beads as described above, then eluting the target nucleic acid from the last set of dT-beads in any convenient buffer. In the following, we demonstrate that reversible target capture can be used to purify HW-1 RNA from crude cell lysate and then amplified by use of the polymerase chain reaction method (7) (8) (9) .
Materials and Methods

Solutions and Probes
Sources of reagents and a description of the devices used in reversible target capture have appeared elsewhere (4,5). 
H9
culture fluid, incubated for 5 h at 37 #{176}C, washed twice with growth medium, then cultured at a density of 6 x iO cells/mL in either medium alone or medium supplemented with Ampligen (50 mgIL). Cells were removed on subsequent days, pelleted, and dissolved in lysis buffer to give a concentration of i0 cells/mL. Fresh medium (containing no drug) was added to all cultures on days that cells were removed to maintain cell densities at 0.25-i X 10 cells/mL.
Molecular Hybridization
Hybridizations were performed essentially as described elsewhere (4). In brief, 20 pL of cell lysate (2 x 10 cells) in lysis buffer was combined with 5 L of 2 x SSC containing 106 counts/mm of labelprobe and 10 ng each of captureprobes 839 and 1197 (5), then incubated at 37 #{176}C for 16 h.
ReversibleTarget Capture
dT-beads were prehybridized in binding buffer overnight at 37#{176}C (4). Hybridization reactions were diluted with 50 L of dT-bead suspension and incubated at 37 #{176}C for 10 mm. The dT-beads were magnetically separated from solution and washed twice with 400 pL of wash buffer. The hybrids were eluted from the dT-beads in 50 L of release buffer by incubating at 37#{176}C for 10 mm. Release buffer containing the hybrids was transferred to a fresh tube, and the hybrids were recaptured onto fresh dT-beads by adding 50 pL of dT-beads suspended in binding buffer and incubating the suspensions at 37 #{176}C for 10 min.
Quantificationof Hybridization
Hybrids were eluted from the third set of dT-beads in 100 L of TE (10 mmol of Tris HC1, pH 8.0, and 1 mmol of EDTA per liter) at 65 #{176}C for 5 mm. The dT-beads were magnetically separated, and the fluid containing the hybrids was applied to Ready Caps (Beckman Instruments, Fullerton, CA) and dried; the radioactivity was counted in a liquid scintillation counter (11). 
Enzymatic Amplification of Purified
RNA H91 lysate was diluted into lysate from the noninfected myeloid
Results
Using probes, reagents, and devices for quantifying concentrations of 11W-i RNA as described elsewhere (5, 6), we examined the effect of the antiviral drug, poly(I):-poly(C12U), or Ampligen, which has previously been shown to inhibit HW-1 replication in vitro (12), on H1V-1 RNA concentrations during acute infection in vitro. One means of overcoming the difficulty of detecting rare mRNA sequences is to amplify the sequences by using the polymerase chain reaction amplification procedure (9). To see if HN-i RNA purified by reversible target capture could serve as a template for enzymatic amplification, we diluted lysate into lysate of the noninfected leukemic blood-cell line, K562, and purified HW-i RNA from the lysates by three cycles of capture. The purified RNA was eluted from the third set of dT-beads, reverse-transcribed into a DNA copy, then enzyniatically amplified (7). The reaction products were analyzed by Southern blot hybridization (Figure 2) . Amplification product of the expected length (220 bp) was observed with lysate in quantities equivalent to as few as 20 H9 cells in a background of 2 x iO noninfected K562 lysate (lane 6). This ratio of infected to noninfected cells corresponds to that found within the peripheral blood of infected individuals (15) . No signal was obtained in the reaction that did not first include the reverse transcription step (lane 2), confirming that signal arose from RNA sequences.
No signal was obtained with K562 lysate alone (lane 7), indicating that signal was dependent upon the presence of H9 lysate in the samples.
DiscussIon
In the strategy described, molecular hybridization was performed directly in crude cell lysate. The advantage is that nucleic acids did not need to be purified before hybridization. Hybrids were purified from cell lysate and unreacted probe by the reversible target capture method (3), which utilizes a bipartite probe, the captureprobe, capable of binding to both the target nucleic acid and to paramagnetic beads. Probes designed to measure 11W-i sequences were used to determine the effect of the antiviral drug, Ampligen, on synthesis of RIV-i RNA during lytic infection in vitro.
Because this purification scheme relies on the ability of the captureprobes to hybidize with their intended target, reversible target capture is also particularly suited for the isolation of specific nucleic acid sequences from crude cell lysate. We demonstrated that RNA purified by this technique can serve as template for enzymatic amplification. The potential to adjust the specificity of purification by adjusting the stringency of the captureprobe hybridization could reduce problems associated with amplification of sequences to which many related sequencesexist. A set of captureprobes could be designed either to cross-react with a variety of related sequences or to react with a single species.
It is apparent from Figure 2 that the conditions used for amplification did not result in the production of signal that was proportional to the amount of target present; e.g., the sample containing lysate from 2000 infected cells (lane 4) generated a signal greater than the sample containing 20 000 infected cells (lane 3). We are currently investigating amplification conditions that will produce quantitative results.
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